rs187389813
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the c.854-32A>C variant in the PTPN11 gene is 15.2% for Latino chromosomes by the Exome Aggregation Consortium (1824/11514 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA215447/MONDO:0021060/004
Frequency
Consequence
NM_002834.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPN11 | NM_002834.5 | c.854-32A>C | intron_variant | ENST00000351677.7 | NP_002825.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPN11 | ENST00000351677.7 | c.854-32A>C | intron_variant | 1 | NM_002834.5 | ENSP00000340944.3 | ||||
PTPN11 | ENST00000635625.1 | c.854-32A>C | intron_variant | 5 | ENSP00000489597.1 |
Frequencies
GnomAD3 genomes AF: 0.00857 AC: 1302AN: 151866Hom.: 71 Cov.: 32
GnomAD3 exomes AF: 0.0204 AC: 5120AN: 251128Hom.: 410 AF XY: 0.0149 AC XY: 2024AN XY: 135720
GnomAD4 exome AF: 0.00446 AC: 6220AN: 1395898Hom.: 492 Cov.: 27 AF XY: 0.00359 AC XY: 2510AN XY: 698430
GnomAD4 genome AF: 0.00861 AC: 1309AN: 151984Hom.: 71 Cov.: 32 AF XY: 0.00993 AC XY: 738AN XY: 74286
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 12, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 03, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Noonan syndrome Benign:1
Benign, no assertion criteria provided | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 29, 2014 | - - |
RASopathy Benign:1
Benign, reviewed by expert panel | curation | ClinGen RASopathy Variant Curation Expert Panel | Apr 03, 2017 | The filtering allele frequency of the c.854-32A>C variant in the PTPN11 gene is 15.2% for Latino chromosomes by the Exome Aggregation Consortium (1824/11514 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert panel for autosomal dominant RASopathy variants (BA1). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at